X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (164) 164
humans (156) 156
oncology (149) 149
female (117) 117
epothilone-b analog (109) 109
ixabepilone (86) 86
breast neoplasms - drug therapy (84) 84
epothilones - therapeutic use (80) 80
chemotherapy (76) 76
bms-247550 (68) 68
breast cancer (68) 68
antineoplastic agents - therapeutic use (67) 67
ixabepilone bms-247550 (59) 59
epothilones - administration & dosage (57) 57
cancer (56) 56
middle aged (56) 56
phase-ii (56) 56
ii clinical-trial (55) 55
anthracycline (54) 54
paclitaxel (54) 54
epothilones - adverse effects (52) 52
adult (51) 51
aged (51) 51
metastatic breast-cancer (51) 51
clinical-trial (48) 48
breast neoplasms - pathology (47) 47
pharmacology & pharmacy (45) 45
capecitabine (44) 44
taxane (43) 43
tubulin modulators - therapeutic use (43) 43
treatment outcome (42) 42
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
epothilones (40) 40
care and treatment (39) 39
drug resistance, neoplasm (39) 39
hematology, oncology and palliative medicine (39) 39
male (39) 39
microtubule-stabilizing agents (38) 38
neoplasm metastasis (38) 38
clinical trials as topic (34) 34
drug therapy (31) 31
epothilone (31) 31
epothilones - pharmacology (31) 31
phase-ii trial (31) 31
advanced solid tumors (30) 30
antineoplastic agents - adverse effects (30) 30
plus capecitabine (30) 30
neoplasms - drug therapy (29) 29
research (29) 29
b analog (28) 28
metastasis (28) 28
taxoids - therapeutic use (28) 28
antineoplastic agents (27) 27
antineoplastic agents - pharmacology (27) 27
daily schedule (27) 27
metastatic breast cancer (27) 27
medicine & public health (26) 26
resistant (26) 26
solid tumors (26) 26
antimitotic agents (24) 24
clinical trials (24) 24
epothilones - pharmacokinetics (24) 24
animals (23) 23
health aspects (23) 23
obstetrics and gynecology (23) 23
antineoplastic agents - administration & dosage (22) 22
dosage and administration (22) 22
1st-line therapy (21) 21
deoxycytidine - analogs & derivatives (21) 21
epothilone-b-analog (21) 21
anthracyclines (20) 20
docetaxel (19) 19
ixabepilone plus capecitabine (19) 19
aged, 80 and over (18) 18
cell lung-cancer (18) 18
fluorouracil - analogs & derivatives (18) 18
pharmacology/toxicology (18) 18
prostate-cancer (18) 18
taxanes (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
peripheral neuropathy (17) 17
southwest-oncology-group (17) 17
drug administration schedule (16) 16
drug resistance (16) 16
tubulin modulators - adverse effects (16) 16
disease-free survival (15) 15
tubulin modulators - pharmacology (15) 15
albumin-bound paclitaxel (14) 14
antineoplastic agents - pharmacokinetics (14) 14
deoxycytidine - administration & dosage (14) 14
efficacy (14) 14
fluorouracil - administration & dosage (14) 14
peripheral nervous system diseases - chemically induced (14) 14
tubulin modulators - administration & dosage (14) 14
b-analog bms-247550 (13) 13
dose-response relationship, drug (13) 13
patient outcomes (13) 13
trial (13) 13
tubulin (13) 13
bevacizumab (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2007, Volume 25, Issue 4, pp. 335 - 341
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 05/2008, Volume 19, Issue 5, pp. 977 - 983
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 33, pp. 5210 - 5217
Journal Article
Journal Article
OncoImmunology, ISSN 2162-4011, 03/2013, Volume 2, Issue 3, pp. e23510 - e23510
It is now clear that the immune system plays a critical role not only during oncogenesis and tumor progression, but also as established neoplastic lesions... 
calreticulin | autophagy | dendritic cells | HMGB1 | ATP | epothilone B | Epothilone B | Calreticulin | Dendritic cells | Autophagy | IXABEPILONE BMS-247550 | RECEPTOR AGONISTS | LOW-DOSE CYCLOPHOSPHAMIDE | TUMOR-CELLS | OPEN-LABEL | IMMUNOLOGY | CALRETICULIN EXPOSURE | MICROTUBULE-STABILIZING AGENTS | EPOTHILONE-B ANALOG | LIPOSOMAL DOXORUBICIN | ONCOLOGY | RANDOMIZED PHASE-II | Review
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 12/2018, Volume 18, Issue 6, pp. 489 - 497
With no approved targeted therapies for triple-negative breast cancer, its management relies on chemotherapy. The current analysis evaluated ixabepilone plus... 
Epothilone | Chemotherapy resistance | Metastatic | TNBC | Combination chemotherapy | SURVIVAL | BMS-247550 | NEOADJUVANT THERAPY | PLUS CAPECITABINE | RESISTANT | EPOTHILONE-B ANALOG | ONCOLOGY | ANTHRACYCLINE | TAXANE | AMERICAN SOCIETY | Usage | Chemotherapy | Safety and security measures | Capecitabine | Breast cancer | Ixabepilone | Drug therapy | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1216 - 1225
Journal Article
Journal Article